Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Frovatriptan for Intermittent Prevention of Menstrual Migraine
NCT00644033Phase 3Completed
- Sponsor
- Endo International plc
- Start
- Jun 2001
- Primary completion
- Jun 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of frovatriptan in menstrual migraine, sponsored by Endo International plc. Started Jun 2001; status: completed.
02
Drugs
frovatriptan
03
Conditions
menstrual migraine
Beyond the preview
Go deeper on NCT00644033.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00644033.